Your session is about to expire
← Back to Search
Behavioural Intervention
RAE Digital Tool for Substance Use Disorder
Phase 2 & 3
Recruiting
Led By Megan Reinhardt
Research Sponsored by ContinueYou, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial will test if digital biomarkers of stress and drug craving can be detected in people with substance abuse disorders, which may help with treatment.
Who is the study for?
This trial is for adults over 18 who are in the early stages (less than 90 days) of outpatient treatment for substance use disorders. Participants must have a smartphone with iOS or Android, speak English fluently, and be able to give informed consent. Pregnant individuals, prisoners, or those with significant arm disabilities cannot participate.Check my eligibility
What is being tested?
The RAE study is testing how well digital biomarkers can detect stress and drug cravings in people getting treated for substance use disorder. It aims to understand if these markers can help improve adherence to treatment programs.See study design
What are the potential side effects?
Since this trial involves monitoring through a smartphone app rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience privacy concerns or emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with return to drug use
Secondary outcome measures
Number of hospitalizations and emergency department visits per participant
Number of participants retained in treatment
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional (RAE + Usual Care)Experimental Treatment1 Intervention
Subjects will receive usual care through an outpatient substance use disorder treatment facility, will be provided with a wearable sensor and the RAE mobile application. Participants will be instructed to use the RAE app for a minimum of 30 days.
Group II: Control (Usual care)Active Control1 Intervention
Subjects will receive usual care through an outpatient substance use disorder treatment facility and will be provided with a wearable sensor (fitness tracker). They will not be given access to the RAE mobile app.
Find a Location
Who is running the clinical trial?
ContinueYou, LLCLead Sponsor
University of Massachusetts, WorcesterOTHER
343 Previous Clinical Trials
986,310 Total Patients Enrolled
University of Texas at TylerOTHER
3 Previous Clinical Trials
209 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My non-dominant arm has limited movement due to amputation or fracture.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Interventional (RAE + Usual Care)
- Group 2: Control (Usual care)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals who suffer from this condition able to enroll in the trial at this time?
"The clinical trial in question is not currently recruiting patients, as indicated by the data on clinicaltrials.gov. This study was first posted on 4/1/2022 and last updated 2/9/2022; while it's no longer looking for participants, there are 376 other studies that are."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger